Results 181 to 190 of about 84,576 (334)

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

New England Journal of Medicine, 2004
V. Pengo, A. Lensing, M. Prins, A. Marchiori, B. Davidson, F. Tiozzo, P. Albanese, A. Biasiolo, Cinzia Pegoraro, S. Iliceto, P. Prandoni   +10 more
semanticscholar   +1 more source

Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.

Journal of the American College of Cardiology, 2023
C. Gerges, A. Pistritto, M. Gerges, R. Friewald, V. Hartig, T. Hofbauer, B. Reil, L. Engel, V. Dannenberg, S. Kastl, N. Skoro-Sajer, B. Moser, S. Taghavi, W. Klepetko, I. Lang   +14 more
semanticscholar   +1 more source

Deep Vein Thrombosis in Critically Ill Patients With COVID‐19 Pneumonia

Journal of Ultrasound in Medicine, Volume 45, Issue 1, Page 155-170, January 2026.
Objectives The risk of major venous thromboembolism (VTE) among patients with COVID‐19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID‐19, validate the Wells score for DVT diagnosis, and determine patients' prognosis.
Clévio Cezar da Fonseca, Hugo Perazzo, Sandra Wagner Cardoso, Isabel Cristina Ferreira Tavares, Maria Pia Diniz Ribeiro, Rodrigo de Carvalho Moreira, Lara Esteves Coelho, Emília Moreira Jalil, André Miguel Japiassú, Elias Pimentel Gouvêa, Estevão Portela Nunes, Hugo Boechat Andrade, Luciano Barros Gouvêa, Marcel Treptow Ferreira, Pedro Mendes Azambuja‐Rodrigues, Ronaldo Ismerio Moreira, Kim Mattos Geraldo, Lucilene Araújo de Freitas, Vinicius Velleda Pacheco, Beatriz Gilda Jegerhorn Grinsztein, Pedro Emmanuel Alvarenga Americano do Brasil   +20 more
wiley   +1 more source

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report

International Journal of General Medicine, 2011
Konstantinos Porpodis1, Maria Konoglou2, Paul Zarogoulidis1, Evangelos Kaimakamis2, Theodoros Kontakiotis1, Despoina Papakosta1, Vasilis Zervas1, Nikolaos Katsikogiannis3, Nikolaos Courcoutsakis4, Alexandros Mitrakas5, Panagiotis Touzopoulos5, Michael ...
Porpodis K, Konoglou M, Zarogoulidis P, Kaimakamis E, Kontakiotis T, Papakosta D, Zervas V, Katsikogiannis N, Courcoutsakis N, Mitrakas A, Touzopoulos P, Karanikas M, Zarogoulidis K, Markopoulou A   +13 more
doaj  

Balloon Pulmonary Angioplasty: Paradigm Shift in Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

, 2023
Chul‐Min Ahn
openalex   +1 more source

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.

The Lancet Respiratory Medicine, 2022
X. Jaïs, P. Brenot, H. Bouvaist, M. Jevnikar, M. Canuet, C. Chabanne, A. Chaouat, V. Cottin, P. De Groote, N. Favrolt, D. Horeau-Langlard, P. Magro, L. Savale, G. Prévôt, S. Renard, O. Sitbon, F. Parent, R. Trésorier, C. Tromeur, C. Piedvache, L. Grimaldi, E. Fadel, D. Montani, M. Humbert, G. Simonneau   +24 more
semanticscholar   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

Andrology, Volume 14, Issue 1, Page 294-302, January 2026.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann, Giulia Rastrelli, Robert D Murray, David Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni, Emiliano Corpas, Jann‐Frederik Cremers, Janine David, Stefan Arver, Leen Antonio, Giovanni Corona   +15 more
wiley   +1 more source

Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review

Pulmonary Circulation
Pulmonary hypertension in sickle cell disease (SCD) is a complex phenomenon resulting from multiple overlapping etiologies, including pulmonary vasoconstriction in the setting of chronic hemolytic anemia, diastolic dysfunction, and chronic thromboembolic
Kadija Hersi, Gautam V. Ramani, Jennie Y. Law, Ahmed S. Sadek, Anjali Vaidya, Mark T. Gladwin, Steven J. Cassady   +6 more
doaj   +1 more source

Evaluation of Two High‐Power Ablation Approaches in the Management of Typical Atrial Flutter: A Retrospective Study

Annals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
To compare the acute and long‐term outcomes of high‐power ablation for typical atrial flutter using a 4‐mm irrigated catheter (4‐IC) versus an 8‐mm non‐irrigated catheter (8‐NIC). We conducted a retrospective cohort study of 215 patients who underwent cavotricuspid isthmus (CTI) ablation between January 2019 and December 2024.
Hina Pervaiz, Farooq Hyder, Aimen Binte Moazzam, Fnu Abdullah, Abida Perveen, Jahanzeb Malik   +5 more
wiley   +1 more source

Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis: Current Evidence and Future Directions

ACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease marked by progressive fibrosis and multi‐organ involvement, most notably in the lungs. Among patients with rapidly progressive diffuse cutaneous SSc and interstitial lung disease (ILD), autologous hematopoietic stem cell transplantation (AHSCT) has emerged as one of the most ...
Cristiana Sieiro Santos
wiley   +1 more source